as on December 23, 2025 at 2:29 am IST
Day's Low
Day's High
2.62%
Downside
1.05%
Upside
52 Week's Low
52 Week's High
27.23%
Downside
1103.40%
Upside
Check Jasper Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$52.1M
EPS (TTM)
-4.8027
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-90.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-191.12%
Compare market cap, revenue, PE, and other key metrics of Jasper Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $52.1M | NA | NA | 0.00% | |
| BUY | $37.5B | 395.8% | -16.34 | -264.83% | |
| BUY | $52.9B | 194.14% | 1429.39 | 1.36% | |
| BUY | $117.0B | 95.18% | 32.15 | 31.35% | |
| BUY | $81.4B | 58.35% | 18.42 | 32.13% |
The Jasper Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Jasper Therapeutics Inc investment value today
Current value as on today
₹14,057
Returns
Returns from Jasper Therapeutics Inc Stock
Dollar Returns*
₹5,422 (+5.42%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Jasper Therapeutics Inc. Average target price of $17.86
Get share price movements and forecasts by analysts on Jasper Therapeutics Inc.
What analysts predicted
89.31%UPSIDE
Target Price
$17.86
Current Price
$1.91
Analyzed by
13 Analysts
Target
$17.86
Jasper Therapeutics Inc target price $17.86, a slight upside of 89.31% compared to current price of $1.91. According to 13 analysts rating.
Search interest for Jasper Therapeutics Inc Stock has increased by 363% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:363% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 15 November
Sun, 07:41 AM
-Rosen Law Firm reminds Jasper investors of November 18 deadline for securities class action regarding misleading statements.
Sat, 05:56 PM
-Faruqi & Faruqi investigates claims against Jasper, highlighting misleading statements and upcoming lead plaintiff deadline.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, JSPR stock has moved up by 11.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 149.0% return, outperforming this stock by 240.4%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 808.3% return, outperforming this stock by 873.8%
| Organisation | Jasper Therapeutics Inc |
| Headquarters | 2200 Bridge Pkwy, Redwood City, CA, United States, 94065 |
| CEO | Mr. Ronald A. Martell |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Judith Anne Shizuru M.D., Ph.D. | Co-Founder, Member of Scientific Advisory Board & Director |
Mr. Herbert C. Cross CPA | CFO & Corporate Secretary |
Mr. Jeetinder Singh Mahal M.B.A. | Chief Operating Officer |
Ms. Patricia Carlos | Senior Vice President of Regulatory Affairs & Quality |
Ms. Kimberly Baxter | VP & Head of Quality |
Mr. Ronald A. Martell | President, CEO & Director |
Mr. Matthew Ford | Senior Vice President of Human Resources |
Dr. Wendy Pang M.D., Ph.D. | Senior Vice President of Research & Translational Medicine |
Dr. Daniel C. Adelman M.D. | Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor |
Dr. Luca Di Noto Ph.D. | Senior Vice President of Technical Operations |
Jasper Therapeutics Inc share price today is $1.91 as on at the close of the market. Jasper Therapeutics Inc share today touched a day high of $1.93 and a low of $1.86.
Jasper Therapeutics Inc share touched a 52 week high of $22.99 on and a 52 week low of $1.39 on . Jasper Therapeutics Inc stock price today i.e. is closed at $1.91,which is 91.69% down from its 52 week high and 37.41% up from its 52 week low.
Jasper Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Jasper Therapeutics Inc (JSPR) shares with as little as ₹89.714 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.14 in Jasper Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Jasper Therapeutics Inc share’s latest price of $1.91 as on December 23, 2025 at 2:29 am IST, you will get 5.2356 shares of Jasper Therapeutics Inc. Learn more about
fractional shares .